Class Action Alert: Investors of Applied Therapeutics, Inc. APLT

Class Action Lawsuit Notification for Investors

If you are an investor in Applied Therapeutics, Inc. (APLT), a recent announcement may be crucial for you. Levi & Korsinsky, LLP is informing shareholders about a class action lawsuit related to alleged securities fraud that could impact financial recoveries significantly.

Case Overview and Background

The lawsuit seeks to represent investors who experienced losses during a specific period. This situation arose from the company's actions and communications from January 3, 2024, to December 2, 2024. It is essential for investors to understand the implications of this notice, especially if they hold or had planned to invest in Applied Therapeutics.

Details of the Alleged Fraud

The legal complaint details that on November 27, 2024, Applied Therapeutics announced significant regulatory news: a Complete Response Letter (CRL) from the FDA regarding its New Drug Application for the company’s primary drug candidate, govorestat. This CRL indicated that the FDA found deficiencies in the clinical application, leading to a substantial decline in the stock price.

Impact on APLT Shareholders

Once the CRL was released, investors observed a dramatic drop in Applied Therapeutics' shares. The stock fell from $10.21 per share before the announcement to just $1.75 by December 2, 2024, marking a staggering loss of over 80%. Furthermore, following an additional disclosure about a warning letter from the FDA related to clinical trials, the stock price fell even further. Such substantial fluctuations can understandably result in significant concerns among current and potential investors.

Next Steps for Affected Investors

Investors who suffered losses during the specified timeframe have a limited window to take action. You have until February 18, 2025, to file your motion to be appointed as lead plaintiff in the class action. Importantly, participating in any recovery does not necessitate being a lead plaintiff, thus making it accessible for all affected investors.

Potential for Compensation Without Costs

For those classified as members of the action, there is potential for compensation without incurring out-of-pocket fees. The law firm Levi & Korsinsky operates on a contingency basis, meaning you won't have to pay upfront costs to participate in the lawsuit.

Why Levi & Korsinsky?

With over two decades of experience, Levi & Korsinsky has built a strong reputation for advocating on behalf of shareholders. They have successfully secured significant settlements in various high-profile securities litigation cases. Their dedicated team focuses on ensuring that investors are protected and compensated for their losses.

Contact Information for Affected Investors

Investors interested in learning more about this lawsuit or seeking assistance can contact the legal representatives at Levi & Korsinsky. Joseph E. Levi, Esq. can be reached at (212) 363-7500 or through email for any inquiries regarding the class action.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit addresses securities fraud allegations related to Applied Therapeutics, Inc. that adversely affected investors within a specific time frame.

How can I participate in the class action?

If you suffered losses with APLT stock, you need to act before February 18, 2025, to request lead plaintiff status or join the action.

Will I have to pay anything to join the lawsuit?

No, there is no upfront cost to join the lawsuit; investors may receive compensation without any out-of-pocket fees.

Who can represent me in this case?

Levi & Korsinsky has extensive experience in securities litigation and will represent affected investors in the case.

What happens if the lawsuit is successful?

Should the lawsuit succeed, investors could receive compensation for their financial losses related to the stock decline.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.